Wilson Sonsini Goodrich & Rosati represented the investors in the transaction.D3 Bio, Inc, a clinical-stage biotechnology announced its closing of a $62 million Series A financing round….
This content is for Standard 1 Year members only. LoginJoin Now
Author: Leila Ahmed
…
This content is for Standard 1 Year members only. LoginJoin Now